Cov-Boost

COV-Boost is an @NIHRresearch funded RCT to evaluate 3rd dose booster vaccinations against COVID-19 We're enrolling people aged 30 and over who have had 2 doses of a COVID-19 vaccine, with the first in December 2020 or January 2021 To find out more visit covboost.org.uk

Research led by @UHSFT has provided vital data for the UK’s #COVID19 booster programmes since 2021. Now, new findings from @CovBoost reveal third-doses offer lasting protection after several months. The insight could be important around the globe. 🌍 clinicalresearch.uhs.nhs.uk/news/uk-wide-c…

Third-dose #COVID19 boosters offer lasting protection after several months, according to the latest results of the @UHSFT-led @CovBoost trial. Our director @SaulFaust explains how this will support global policymaking. 🏥🌍 southamptoncrf.nihr.ac.uk/post/uk-wide-c…

Our second blog post in the @CovBoost series is now out!💜 Today we have an insight into @LeilaJTF's experience. She joined COV-Boost at the set up stage so has been involved from the beginning. Read more below on her experience on the trial! 👇👇👇 statsci.co.uk/post/spotlight…

New week, new blog!💪 @LeilaJTF and @Annie_Stats have a new series on their experiences working on the @CovBoost trial as statisticians✨ Read the first in the series below and follow along for the rest of the week for the other instalments! 👇👇👇 statsci.co.uk/post/spotlight…

Would you like to be part of a Bivalent Omicron variant COVID-19 vaccine study? If you've had three doses of COVID-19 vaccine and have not tested positive for COVID-19 in the last 3 months we would like to hear from you! For more information click 👇 covboost.org.uk/participate-bi

Thank you for the exceptional hard work, flexibility and dedication to studies such as @CovBoost 👏#BiomedicalScienceDay2022

Ahead of Friday's #ClinicalTrialsDay, we want to celebrate those who volunteer and get involved in research - the TrialBlazers. Over the next 2 weeks we'll be sharing their stories and examples of how you can #BePartOfResearch and join the TrialBlazers 🦸‍♂️ bepartofresearch.nihr.ac.uk/trialblazers/?…

Great to see the outstanding work of the @southamptonCRF receiving such prominent national media coverage today. The Southampton-led @Covboost study has important findings for fourth dose #covid jabs in the UK and beyond.

Fourth doses of #covid vaccines have been offered to the most vulnerable in the UK and a wider group might get them later this year. Latest findings from the @southamptonCRF @Covboost study show these jabs offer excellent boosting immunity protection. bit.ly/3vZM3IM

The results of the @CovBoost fourth dose booster substudy are now online in @TheLancetInfDis We demonstrated fourth doses of covid vaccines were safe and well tolerated and boost antibody levels above their peak following a third dose thelancet.com/journals/lanin…

Summary: - Drops in S IgG by up to ~half by day 84 - Small drop for T cells - S IgG drop more for mRNA boosters - After 2x BNT, day 84 S IgG as good or better following Adenovirus boosters vs mRNA - Reduced but still good neutralisation vs omicron at day 28 for mRNA boosters 9/

Excited to finally share the @CovBoost data on persistence of immunity following third dose boosters for #COVID19 It makes a real difference which booster you get depending on your primary vaccine course Tonnes of data here - let's take a look! 🧵 1/ journalofinfection.com/article/S0163-…

The Southampton-led @CovBoost study provided world-first data on the safety of third vaccine doses, guiding the UK’s autumn 2021 booster rollout. New results from the nationwide study show the lasting impact of booster jabs in staying protected from #COVID19

#Covid19 #vaccination study alert! Open in @LTHTResearch the @CovBoost study is inviting 18-30 year olds looking at the use of different COVID-19 vaccines and doses for giving a third dose. Interested, contact leedsth-tr.covboostvaccine@nhs.net or call 07425 628243.

If you’re 18-30 & haven’t had your #COVID19 booster yet, you may be eligible for Cov-Boost. The study looks at the effectiveness of different doses of Pfizer & Moderna. Receive up to £225 (depending on no. of visits) to cover travel & inconvenience. covboost.org.uk

A new sub-study of @CovBoost, trialling lower #covid19 vaccine booster doses has launched. The study will take place at 15 hospitals across England, Wales and Scotland, and will include a total of over 900 participants.bit.ly/3rJncpc

Are you aged 18 - 30 and have had 2 doses of a #COVID19 vaccine? You may be eligible for our new sub-study, trialling lower doses of the Pfizer and Moderna vaccines as 3rd dose boosters for young adults! Click here to find out more 👇 covboost.org.uk/participate-su…

The UKHSA played a key role in the laboratory testing of samples from the @CovBoost trial, which assessed possible vaccines for the UK’s booster rollout. We will shortly begin testing samples from the trial against the new #OmicronVariant to assess their effectiveness.

Results from the UK-wide trial @CovBoost shows that six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech. Read more: bit.ly/3lvzmQd

We are delighted to be able to share the results of the @CovBoost trial which were published in @TheLancet overnight. @SaulFaust, trial lead, said: “Southampton’s #CovBoost trial has informed the UK which boosters are safe to use this winter.” Read more: uhs.nhs.uk/whats-new/pres…